Your browser doesn't support javascript.
loading
Prediction of S-1 adjuvant chemotherapy benefit in Stage II/III gastric cancer treatment based on comprehensive gene expression analysis.
Nakamura, Kenichi; Hatakeyama, Keiichi; Furukawa, Kenichiro; Fujiya, Keiichi; Kamiya, Satoshi; Hikage, Makoto; Tanizawa, Yutaka; Bando, Etsuro; Ohshima, Keiichi; Urakami, Kenichi; Machida, Nozomu; Yasui, Hirofumi; Yamaguchi, Ken; Terashima, Masanori.
Affiliation
  • Nakamura K; Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Hatakeyama K; Medical Genetics Division, Research Institute, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Furukawa K; Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Fujiya K; Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Kamiya S; Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Hikage M; Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Tanizawa Y; Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Bando E; Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Ohshima K; Medical Genetics Division, Research Institute, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Urakami K; Cancer Diagnostics Research Division, Research Institute, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Machida N; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Yasui H; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Yamaguchi K; Research Institute, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan.
  • Terashima M; Division of Gastric Surgery, Shizuoka Cancer Center, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka, 411-8777, Japan. m.terashima@scchr.jp.
Gastric Cancer ; 23(4): 648-658, 2020 07.
Article in En | MEDLINE | ID: mdl-32185558
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Stomach Neoplasms / Biomarkers, Tumor / Tegafur / Chemotherapy, Adjuvant / Gene Expression Profiling / Antimetabolites, Antineoplastic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Japan Country of publication: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oxonic Acid / Stomach Neoplasms / Biomarkers, Tumor / Tegafur / Chemotherapy, Adjuvant / Gene Expression Profiling / Antimetabolites, Antineoplastic Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Gastric Cancer Journal subject: GASTROENTEROLOGIA / NEOPLASIAS Year: 2020 Document type: Article Affiliation country: Japan Country of publication: Japan